SUBSCRIBE
SUBSCRIBE
News   Policy

Servier on Trial Over Diabetes-Diet Pill

May 14, 2012 | 
1 min read
(Reuters) - French drugmaker Servier and its founder went on trial on Monday accused of misleading patients and authorities about a diabetes drug often prescribed for weight loss that officials blame for at least 500 deaths.
Legal Europe
MORE ON THIS TOPIC
FDA headquarters with a purple psychedelic background.
Psychedelics
Final psychedelics guidance suggests FDA is ‘receptive’ to helping companies succeed
July 14, 2026
 · 
3 min read
 · 
Michael Gibney
Project management vector icon. Pixel perfect vector graphics
Manufacturing
FDA proposes streamlined requirements for ‘hub-and-spoke’ manufacturing models
July 14, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Editorial
Biotech’s China problem: An issue of national security or economic value for the US?
July 2, 2026
 · 
6 min read
 · 
Jef Akst
Approved and confirmed document file with check mark icon flat cartoon, concept of agreement or contract symbol with checkmark, accepted or certified license paper form pictogram isolated image
Manufacturing
Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program
July 1, 2026
 · 
2 min read
 · 
Nick Paul Taylor